Analysts expect that Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will announce sales of $30.11 billion for the current quarter, Zacks reports. Seven analysts have provided estimates for Walgreens Boots Alliance’s earnings, with estimates ranging from $29.25 billion to $30.66 billion. Walgreens Boots Alliance reported sales of $28.64 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 5.1%. The company is scheduled to report its next earnings report before the market opens on Wednesday, October 25th.

According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year sales of $30.11 billion for the current fiscal year, with estimates ranging from $117.32 billion to $118.78 billion. For the next year, analysts anticipate that the firm will post sales of $127.67 billion per share, with estimates ranging from $121.63 billion to $133.53 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Walgreens Boots Alliance.

A number of equities analysts have issued reports on WBA shares. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, June 24th. Needham & Company LLC started coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, June 27th. They issued a “hold” rating on the stock. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $77.00 price objective (down previously from $89.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, June 28th. Finally, Pivotal Research set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a report on Sunday, July 2nd. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $92.06.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/04/analysts-expect-walgreens-boots-alliance-inc-wba-will-announce-quarterly-sales-of-30-11-billion.html.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now directly owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 13.50% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Hudock Capital Group LLC raised its holdings in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the period. Modera Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% during the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after purchasing an additional 9 shares during the period. Flagship Harbor Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock worth $243,000 after purchasing an additional 16 shares during the period. Sowell Financial Services LLC increased its stake in shares of Walgreens Boots Alliance by 0.6% during the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock worth $218,000 after purchasing an additional 17 shares during the period. Finally, WealthTrust Arizona LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% during the second quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock worth $412,000 after purchasing an additional 21 shares during the period. 60.16% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 76.79 on Wednesday. The stock has a market cap of $82.17 billion, a PE ratio of 19.39 and a beta of 1.25. The company has a 50-day moving average price of $80.49 and a 200-day moving average price of $81.30. Walgreens Boots Alliance has a 52 week low of $75.18 and a 52 week high of $89.69.

Walgreens Boots Alliance announced that its Board of Directors has initiated a stock repurchase plan on Thursday, June 29th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its stock is undervalued.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.08%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.